amifostine anhydrous has been researched along with Anterior Horn Cell Disease in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yalcin, S | 1 |
Nurlu, G | 1 |
Orhan, B | 1 |
Zeybek, D | 1 |
Müftüoğlu, S | 1 |
Sarer, B | 1 |
Yildirim, BA | 1 |
Cetin, E | 1 |
1 other study available for amifostine anhydrous and Anterior Horn Cell Disease
Article | Year |
---|---|
Protective effect of amifostine against cisplatin-induced motor neuropathy in rat.
Topics: Amifostine; Animals; Antineoplastic Agents; Cisplatin; Female; Motor Neuron Disease; Motor Neurons; | 2003 |